Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients

  1. Home
  2. Research Articles
Journal Title: 
Leukemia
Primary Author: 
Santini, V
Author(s): 
Valeria Santini, Pierre Fenaux, Aristoteles Giagounidis, Uwe Platzbecker, Alan F List, Torsten Haferlach, Jim Zhong, Chengqing Wu, Konstantinos Mavrommatis, C L Beach, Kyle J MacBeth, Antonio Almeida
Original Publication Date: 
Monday, July 13, 2020
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/32661294/
Bone Marrow Disease(s):